# Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical Trials

> **NCT06888089** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 20707 (actual)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** AI-assisted MatchMiner Platform

## Key facts

- **NCT ID:** NCT06888089
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-30
- **Primary completion:** 2024-07-15
- **Final completion:** 2024-07-15
- **Target enrollment:** 20707 (ACTUAL)
- **Last updated:** 2025-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06888089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06888089, "Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical Trials". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06888089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*